# Rezo Therapeutics

> Biotech mapping disease networks from UCSF QBI technology for precision therapeutics.

## Why it is interesting

Rezo spun out Krogan/Shokat lab work integrating proteomics and genetics into druggable network maps — a16z Bio co-led the launch round with SR One.

## Profile

- **Stage:** series-a
- **Status:** private
- **Industries:** biotech-life-sciences, healthtech
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Series A (Nov 2022): $78M co-led by SR One, a16z Bio + Health, and Norwest (Rezo press)
- Co-investors not in VCT directory: SR One, SV Angel, Liquid 2 Ventures, Hawktail
- Source: https://rezotx.com/rezo-founded-by-renowned-ucsf-scientists-launches-with-78-million-series-a-to-advance-pipeline-of-precision-therapeutics-based-on-groundbreaking-integrated-disease-network-mapping-platform/

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz
- https://venturecapitaltracker.com/fund/norwest-venture-partners

## Related articles

- https://venturecapitaltracker.com/2026-a16z-hot-portfolio-companies

---
Source: https://venturecapitaltracker.com/startup/rezo-therapeutics